Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEVRALCAR
- Development stage
- Unknown
- Lead developer
- RiverPharma
- Administration
- Oral
01
Overview
**NEVRALCAR** is a River Pharma nutraceutical product family for neuropathic symptom support rather than a single, compositionally defined drug. Public River Pharma materials identify distinct products under this name, including **Nevralcar 1000**, a slow-release oral supplement containing acetyl-L-carnitine, minerals, and vitamins for metabolic neuropathy, and **Nevralcar Duo**, an oral modified-release supplement containing acetyl-L-carnitine, citicoline, and clove-derived beta-caryophyllene for neuropathy of joint or metabolic origin. The supplied characterization as a hyaluronic acid-based product is not supported by the identified product descriptions.
- Brand names
- NEVRALCAR
Beyond the preview
Go deeper on NEVRALCAR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NEVRALCAR.